Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™
Dr. Rahhal, a leading retinal clinician, offered insight on wet AMD treatment and the potential…
Dr. Rahhal, a leading retinal clinician, offered insight on wet AMD treatment and the potential…
Immunosynthen ADCs activate the STING pathway in both tumor-resident immune cells and in the tumor…
IND filing today for STI-2099 (COVI-DROPS™) for a phase 1 safety and pharmacokinetic study in…
Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed…
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a…
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Better Choice Company (OTCQB: BTTR) (“Better Choice”),…
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Cybin Inc. (NEO: CYBN)…
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
–Preclinical data highlight Jounce’s approach to identify potential predictive and pharmacodynamic biomarkers to identify patients…
DUBLIN, Ireland, Nov. 11, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) — Receptor Life Sciences (Receptor) today announced the appointment…
NEWARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Will also present at Jefferies 2020 Virtual London Healthcare Conference CEO to participate in a…
SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Kronos Bio, Inc….
Interim Phase 1 data in patients with relapsed/refractory Ewing sarcoma treated at the recommended Phase…
Operating the SAMI viewed as both simple and safe by the nurses Successful remote deployment…